D-Pinitol attenuates postmenopausal symptoms in ovariectomized mice

Life Sci. 2023 Nov 15:333:122147. doi: 10.1016/j.lfs.2023.122147. Epub 2023 Oct 5.

Abstract

Aims: Menopause is a natural process in women that can lead to post-menopausal syndrome with symptoms such as hot flushes, weight gain, anxiety, cognitive decline, and depression. Hormonal replacement therapy is commonly prescribed. However, it has serious adverse effects. Herbal medicinal products and isoflavones are used as alternatives. D-Pinitol found in Pinaceae and Fabaceae families has anti-inflammatory and antioxidant effects. However, it has not received as much attention as isoflavones. In this study, we investigated whether D-pinitol could alleviate post-menopausal symptoms using an ovariectomized (OVX) mouse model.

Main methods: Female ICR mice were divided into six groups: sham (vehicle), OVX (vehicle), OVX + D-pinitol (10, 30, 100 mg/kg, p.o.), and OVX + estradiol (0.5 mg/kg, s.c.). Treatment with vehicle, D-pinitol, and estradiol began at seven weeks post ovariectomy. We employed several behavioral tests, hot-flush test, and Western blot analysis.

Key findings: We found that D-pinitol treatment (30, 100 mg/kg, p.o.) reversed cognitive dysfunction in OVX mice (novel object recognition and Y-maze test). Additionally, D-pinitol alleviated anxiety-like behaviors (elevated plus-maze) and reversed depressive-like behaviors (splash test, tail suspension test). It also normalized increased basal tail skin temperature in OVX mice. Moreover, D-pinitol administration reversed decreased expression of ERβ and synaptophysin and phosphorylation of ERK and PI3K-Akt-GSK-3β induced by OVX in the hippocampus and prefrontal cortex.

Significance: These findings indicate that D-pinitol might be a promising candidate for treating post-menopausal symptoms by increasing ERβ and synaptophysin expression levels and activation of ERK or PI3K-Akt-GSK-3β signaling pathway, at least in part.

Keywords: Anxiety; Cognitive decline; D-Pinitol; Depression; Ovariectomy; Post-menopausal syndrome.

MeSH terms

  • Animals
  • Estradiol / pharmacology
  • Estrogen Receptor beta
  • Female
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Isoflavones* / pharmacology
  • Mice
  • Mice, Inbred ICR
  • Ovariectomy / adverse effects
  • Phosphatidylinositol 3-Kinases
  • Postmenopause*
  • Proto-Oncogene Proteins c-akt
  • Synaptophysin / pharmacology

Substances

  • Glycogen Synthase Kinase 3 beta
  • Synaptophysin
  • Proto-Oncogene Proteins c-akt
  • pinitol
  • Estrogen Receptor beta
  • Phosphatidylinositol 3-Kinases
  • Estradiol
  • Isoflavones